Related Experiment Videos
RNA as a target for small molecules
1Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Current Opinion in Chemical Biology
|December 5, 2000
Summary
RNA offers a novel drug discovery target by interfering with the translational process. Small molecules can bind mRNA sequence-specifically, impacting pathogen survival and disease progression.
Area of Science:
- Molecular Biology
- Drug Discovery
- RNA Therapeutics
Background:
- Traditional drug discovery targets protein binding sites.
- RNA plays critical roles in pathogen survival and disease progression.
- Accumulating structural and functional RNA information enables new therapeutic strategies.
Purpose of the Study:
- To highlight RNA as an alternative drug discovery target.
- To explore the potential of small molecules targeting the translational process.
- To discuss RNA sequence-specific binding for therapeutic intervention.
Main Methods:
- Review of RNA's role in biological processes.
- Analysis of small molecule interactions with mRNA.
- Case study of aminoglycoside antibiotics binding to 16S ribosomal RNA.
Main Results:
- RNA targeting offers an upstream approach to drug discovery.
- Small molecules can specifically inhibit mRNA translation.
- Aminoglycoside-RNA interactions provide a model for RNA-targeted drug development.
Conclusions:
- RNA presents a promising and underexplored target for novel therapeutics.
- Sequence-specific small molecules can modulate RNA function.
- Further research into RNA-targeted therapies is warranted.